COMP <GO>
HSIC vs UNH // 10Y YIELD & FRED MACRO BETA
Henry Schein Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: HSIC 5
— UNH 9
▲ 10Y YIELD & FRED MACRO BETA LEADER: HSIC
LAST: $84.88 (-1.80%) • MKT CAP: $9.63B
macro-sensitivity
0.89
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
macro-sensitivity
0.33
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HSIC VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HSIC | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 31.10% | 88.57% | -57.47 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.20% | 11.47% | -0.27 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.5x | 16.4x | -6.95 | HSIC | /valuation <GO> |
| Free Cash Flow Yield | 1.23% | 6.48% | -5.25 | UNH | /fcf-yield <GO> |
| Operating Margin | 5.00% | 4.82% | +0.18 | HSIC | /operating-margins <GO> |
| Net Profit Margin | 3.20% | 3.14% | +0.06 | HSIC | /net-margins <GO> |
| Revenue Growth (YoY) | 4.00% | 6.46% | -2.46 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.81 | 3.12 | -0.31 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.50% | 6.74% | -0.24 | HSIC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.8 | 56.0 | -8.25 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.89 | 0.33 | +0.56 | HSIC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.4x | 17.1x | +4.31 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.63B | $364.66B | -$355.03B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HSIC REV | UNH REV | HSIC GROSS % | UNH GROSS % | HSIC FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $13.18B | $447.57B | 31.1% | 88.7% | $118.7M | $16.07B |
| FY 2024 | $12.67B | $400.28B | 31.7% | 88.3% | $277.7M | $20.70B |
| FY 2023 | $12.34B | $371.62B | 44.0% | 89.6% | -$55.3M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HSIC // BETA 0.89
UNH // BETA 0.33